Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004

作者: Kuo ChenYen Kuo ChenYen , Su LinHui Su LinHui , J Perera , C Carlos , Tan BanHock Tan BanHock

DOI:

关键词:

摘要: BACKGROUND AND PURPOSE Shigellosis is a major health problem in developing countries, causing 91 million episodes and 414,000 deaths Asia annually. Because of increasing trends towards drug resistance, this study was undertaken to monitor local resistance patterns Shigella isolates from 8 Asian countries. METHODS Ninety eight collected centers countries July 2001 2004 were analyzed terms serogroup distribution antimicrobial susceptibility. RESULTS The most common flexneri (49/98, 50%), followed by sonnei (44/98, 45%). highest rate found for trimethoprim-sulfamethoxazole (81%), tetracycline (74%) ampicillin (53%). Overall, 76 (78%) multidrug-resistant strains; S. had higher multidrug than (74% vs 23%). Increasing ciprofloxacin ceftriaxone observed; approximately 10% 5% resistant ceftriaxone, respectively. Five ceftriaxone-non-susceptible strains (from Taiwan [3], Hong Kong [1] Philippines [1]) 10 ciprofloxacin-non-susceptible [2], [1], Korea Vietnam [4] Sri Lanka isolated. CONCLUSIONS High rates steady increases are serious pubic concerns Continuous monitoring among necessary.

参考文章(18)
SUSAN JICK, Ciprofloxacin safety in a pediatric population. Pediatric Infectious Disease Journal. ,vol. 16, pp. 130- 134 ,(1997) , 10.1097/00006454-199701000-00037
Myron J. Tong, Clinical and Bacteriological Evaluation of Antibiotic Treatment in Shigellosis JAMA: The Journal of the American Medical Association. ,vol. 214, pp. 1841- 1844 ,(1970) , 10.1001/JAMA.1970.03180100035006
S. MARAKI, A. GEORGILADAKIS, A. CHRISTIDOU, E. SCOULICA, Y. TSELENTIS, Antimicrobial susceptibilities and beta‐lactamase production of Shigella isolates in Crete, Greece, during the period 1991–1995 Apmis. ,vol. 106, pp. 879- 883 ,(1998) , 10.1111/J.1699-0463.1998.TB00234.X
SK Bhattacharya, MK Bhattacharya, D Dutta, S Dutta, M Deb, A Deb, KP Das, H Koley, GB Nair, Double‐blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children Acta Paediatrica. ,vol. 86, pp. 319- 320 ,(1997) , 10.1111/J.1651-2227.1997.TB08898.X
J. Y. Oh, H. S. Yu, S. K. Kim, S. Y. Seol, D. T. Cho, J. C. Lee, Changes in Patterns of Antimicrobial Susceptibility and Integron Carriage among Shigella sonnei Isolates from Southwestern Korea during Epidemic Periods Journal of Clinical Microbiology. ,vol. 41, pp. 421- 423 ,(2003) , 10.1128/JCM.41.1.421-423.2003
BARBARA HAMPEL, RAINER HULLMANN, HEIKE SCHMIDT, Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report. Pediatric Infectious Disease Journal. ,vol. 16, pp. 127- 129 ,(1997) , 10.1097/00006454-199701000-00036
M. L. Replogle, D. W. Fleming, P. R. Cieslak, Emergence of Antimicrobial-Resistant Shigellosis in Oregon Clinical Infectious Diseases. ,vol. 30, pp. 515- 519 ,(2000) , 10.1086/313715
S. Ashkenazi, M. May-Zahav, G. Dinari, U. Gabbay, R. Zilberberg, Z. Samra, Recent Trends in the Epidemiology of Shigella Species in Israel Clinical Infectious Diseases. ,vol. 17, pp. 897- 899 ,(1993) , 10.1093/CLINIDS/17.5.897
Yu-Yu Chuang, Yhu-Chering Huang, Seng-Yi Lin, Outbreak of Shigella sonnei gastroenteritis in Northeastern Taiwan. Pediatric Infectious Disease Journal. ,vol. 25, pp. 92- 94 ,(2006) , 10.1097/01.INF.0000198747.54971.B2